文献速递神经肿瘤

美国退伍军人中的脑肿瘤

Brain tumors in United States military veterans.
PubMed 文献 · Neuro Oncol · 2024-01-01

该研究基于退伍军人健康管理局企业数据仓库2004至2018年数据,分析退伍军人原发性脑肿瘤的发病率和生存结局,并与美国普通人群比较;退伍军人脑肿瘤年龄调整年发病率(AAIR)为11.6/10万,非恶性垂体瘤(AAIR 2.96)、非恶性脑膜瘤(AAIR 2.62)和胶质母细胞瘤(AAIR 1.96)最常见,生存随年龄增长而变差,胶质母细胞瘤患者生存最低;作者认为差异可主要归因于两组人群的人口学构成不同。

要点

  • 退伍军人原发性脑肿瘤总体AAIR为11.6/10万,非恶性肿瘤AAIR 7.19高于恶性肿瘤AAIR 4.42。
  • 退伍军人中最常见为无恶性垂体瘤(AAIR 2.96)、非恶性脑膜瘤(AAIR 2.62)和胶质母细胞瘤(AAIR 1.96)。
  • 退伍军人脑肿瘤生存随年龄增长而变差,胶质母细胞瘤患者生存最低。

核心结论

  • 退伍军人与美国普通人群之间的脑肿瘤差异可 broadly 归因于两组人群的人口学构成差异。
  • 此前尚无关于退伍军人国家级发病率和生存结局的报告,这些数据可为理解疾病负担和改善原发性脑肿瘤患者结局提供重要信息。

研究设计与样本

  • 退伍军人数据来自退伍军人健康管理局(VHA)医疗中心的企业数据仓库,美国普通人群脑肿瘤统计来自美国中央脑肿瘤登记处数据。
  • 研究对象为2004年至2018年诊断的原发性脑肿瘤患者(年龄≥18岁),估计每10万人的平均年龄调整年发病率(AAIR)及95%置信区间,并用Kaplan-Meier生存曲线评估退伍军人总生存结局。

主要发现

  • 退伍军人人群以白人(78%)、男性(93%)和60至64岁(18%)为主;美国普通人群原发性脑肿瘤患者主要为女性(59%)和18至49岁(28%)。
  • 2004年至2018年退伍军人事务部癌症登记处原发性脑肿瘤总体AAIR为11.6,非恶性肿瘤AAIR 7.19高于恶性肿瘤AAIR 4.42。
  • 退伍军人中最常诊断的肿瘤为非恶性垂体瘤(AAIR 2.96)、非恶性脑膜瘤(AAIR 2.62)和胶质母细胞瘤(AAIR 1.96)。
  • 在退伍军人中,生存结局随年龄增长而变差,胶质母细胞瘤患者的生存最低。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Comprehensive analysis of brain tumor incidence and survival in the Veteran population has been lacking. METHODS: Veteran data were obtained from the Veterans Health Administration (VHA) Medical Centers via VHA Corporate Data Warehouse. Brain tumor statistics on the overall US population were generated from the Central Brain Tumor Registry of the US data. Cases were individuals (≥18 years) with a primary brain tumor, diagnosed between 2004 and 2018. The average annual age-adjusted incidence rates (AAIR) and 95% confidence intervals were estimated per 100 000 population and Kaplan-Meier survival curves evaluated overall survival outcomes among Veterans. RESULTS: The Veteran population was primarily white (78%), male (93%), and between 60 and 64 years old (18%). Individuals with a primary brain tumor in the general US population were mainly female (59%) and between 18 and 49 years old (28%). The overall AAIR of primary brain tumors from 2004 to 2018 within the Veterans Affairs cancer registry was 11.6. Nonmalignant tumors were more common than malignant tumors (AAIR:7.19 vs 4.42). The most diagnosed tumors in Veterans were nonmalignant pituitary tumors (AAIR:2.96), nonmalignant meningioma (AAIR:2.62), and glioblastoma (AAIR:1.96). In the Veteran population, survival outcomes became worse with age and were lowest among individuals diagnosed with glioblastoma. CONCLUSIONS: Differences between Veteran and US populations can be broadly attributed to demographic composition differences of these groups. Prior to this, there have been no reports on national-level incidence rates and survival outcomes for Veterans. These data provide vital information that can drive efforts to understand disease burden and improve outcomes for individuals with primary brain tumors.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Bihn JR, Cioffi G, Waite KA, et al. Brain tumors in United States military veterans. Neuro Oncol. 2024. PMID: 37738677. doi:10.1093/neuonc/noad182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。